Incoming CEO - Vitrolife
Wednesday 31 May 09:45 - 10:30
On August 1, 2023, I will become the CEO of Vitrolife AB, a global leader in IVF care.
Prior to that, I was the Global President of the ImmunoDiagnostics Division, at Thermo Fisher Scientific.
I have over twenty years’ experience in the medical device industry having previously worked for Medtronic and Johnson & Johnson. I sit on the board of MedTech Europe, and I also serve on the Operations Management Committee representing the IVD industry in the region. I am a graduate of Dublin City University with an MBA and a Bachelor of Arts degree in International Business & Languages.